Navigation Links
Cholesterol-lowering drugs may reduce mortality for influenza patients
Date:12/16/2011

Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by the Journal of Infectious Diseases.

It is the first published observational study to evaluate the relationship between statin use and mortality in hospitalized patients with laboratory-confirmed influenza virus infection, according to Vanderbilt's William Schaffner, M.D., professor and chair of Preventive Medicine.

"We may be able to combine statins with antiviral drugs to provide better treatment for patients seriously ill with influenza," said Schaffner, who co-authored the study led by Meredith Vandermeer, MPH, of the Oregon Public Health Division.

Researchers studied adults who were hospitalized with laboratory-confirmed influenza from 2007-2008 to evaluate the association between patients who were prescribed statins and influenza-related deaths.

Among 3,043 hospitalized patients with laboratory-confirmed influenza, 33 percent were given statin medications prior to or during hospitalization. After adjusting for various factors, researchers found that patients not receiving statins were almost twice as likely to die from influenza as those who received the medication.

Schaffner stressed that receiving the influenza vaccine each year is still the best defense against influenza. The Centers for Disease Control and Prevention (CDC) estimates that between 5 percent and 20 percent of U.S. residents get the flu each year, and more than 20,000 persons are hospitalized for flu-related complications.


'/>"/>
Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert  

Page: 1

Related medicine news :

1. Cholesterol-lowering drug shrinks enlarged prostates in hamster model
2. Cholesterol-lowering drugs may help prevent recurrent strokes in younger people
3. Cholesterol-Lowering Drugs Safe for Long-Term Use, Study Finds
4. Cholesterol-lowering medication accelerates depletion of plaque in arteries
5. The private sale of drugs in public hospitals
6. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
7. Adapting to clogged airways makes common pathogen resist powerful drugs
8. Diabetes Drugs Avandia, Actos Tied to Fractures in Women
9. Drugs That Shift Cells Energy Find New Purpose
10. FDA Tightens Controls on Anemia Drugs
11. FDA Issues Warning on Key Asthma Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cholesterol-lowering drugs may reduce mortality for influenza patients
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... improved supplement, Healthful-Flex. , The company, owned and operated by Ed Stroup, ... at a reasonable price with the highest level of customer service. Healthful Balance ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... as well as Palm Desert, is opening a new office in San Clemente, ... transcranial magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling with major ...
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, ... the fourth Cradle to Cradle Product Design Challenge , the Cradle to ... series of six circular design challenges scheduled to run through early 2018. The challenges ...
(Date:1/17/2017)... Gatos, CA (PRWEB) , ... January 17, 2017 , ... ... announced the results of a double blind clinical study for its dental gel that ... a leading national brand of toothpaste containing triclosan. The study was conducted at the ...
(Date:1/17/2017)... ... ... people make New Year’s resolutions or renew their commitment to better health with the start ... who want to kick off 2017 with better smiles. Dr. Mondavi is offering several promotions ... include: , , A new patient package for just $49, which ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017   Anesthesia Business ... and practice management for the anesthesia and pain ... which remains a "clinical conundrum" (as described recently ... pain practitioners to think carefully before recommending medical ... report by the National Academies of Sciences, Engineering ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2017 ... clinical stage biopharmaceutical company, announced today that it will ... International Symposium on Acute Leukemias (ISAL) XVI in ... symposium is entitled:  "Reinforcing the Efficacy of Immunotherapy for ... will take place on Monday February 20 th , 2017 ...
(Date:1/17/2017)... Ind. , Jan. 17, 2017  Zimmer Biomet ... in musculoskeletal healthcare , today announced that ... on the strength of the Zimmer Biomet management ... Delp will assume the position of President, ... the Company. Mr. Delp previously served as Zimmer Biomet,s ...
Breaking Medicine Technology: